Visualizations show you which patients and sites have the highest virus-related indicator scores, and visit forecasts allow you to focus your time where it is needed most, first. Filtering includes subject populations at-risk, based on age range and immunocompromised status.
elluminate COVID-19 Analytics Standard Visualizations include:
Recorded Live: April 8, 2020
Vice President of Product Management and clinical data strategy expert Robert Musterer share the benefits of elluminate COVID-19 Analytics and demonstrates the out-the-box visualizations in this live 1-hour webcast. You will learn more about this offering and best practices for effectively using analytics and the elluminate Clinical Data Hub to mitigate COVID-19 associated risk.
“Which patients have missed visits that may require “…specific information in the case report form that explains the basis of the missing data, including the relationship to COVID-19 for missing protocol-specified information (e.g., from missed study visits or study discontinuations due to COVID-19).
“Trial participants may not be able to come to the investigational site for protocol-specified visits,” allowing sponsors to evaluate “whether alternative methods for safety assessments (e.g., phone contact, virtual visit, alternative location for assessment, including local labs or imaging centers) could be implemented when necessary and feasible,”
“Trial participants who no longer have access to investigational product or the investigational site may need additional safety monitoring (e.g. withdrawal of an active investigational treatment)…
Webinar: Introducing elluminate COVID-19 Analytics
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
Blog: How Groundhog Day Inspired COVID-19 Clinical Trial Analytics
Get the Facts
April 7, 2019 Press Release: eClinical Solutions Delivers elluminate COVID-19 Clinical Trial Analytics
Live 30-min Webinar: Intro to elluminate
COVID-19: Developing Drugs and Biological Products for Treatment or Prevention
